VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
Nintendo Co., Ltd. vs Amgen Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Nintendo Co., Ltd.
7974.JP · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nintendo Co., Ltd.'s moat claims, evidence, and risks.
View 7974.JP analysisAmgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Nintendo Co., Ltd. leads (76 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Nintendo Co., Ltd. has 3 segments (90.2% in Nintendo Switch platform ecosystem); Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Nintendo Co., Ltd. has 5 moat types across 3 domains; Amgen Inc. has 5 across 3.
Primary market context
Nintendo Co., Ltd.
Nintendo Switch platform ecosystem
Dedicated console gaming platform ecosystem (hardware + software + digital storefront + online services)
Global
Consumers
Platform owner / first-party publisher
90.2%
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Side-by-side metrics
Moat coverage
Shared moat types
Nintendo Co., Ltd. strengths
Amgen Inc. strengths
Segment mix
Nintendo Co., Ltd. segments
Full profile >Nintendo Switch platform ecosystem
Oligopoly
Mobile and IP-related income
Competitive
Other products and legacy platforms
Competitive
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.